05UF37Z
Supplement Cephalic Vein, Left to No Qualifier with Autologous Tissue Substitute, Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | 5 Upper Veins |
| Operation | U Supplement |
| Body Part | F Cephalic Vein, Left |
| Approach | 3 Percutaneous |
| Device | 7 Autologous Tissue Substitute |
| Qualifier | Z No Qualifier |
Operation Definition
Putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part
Procedure Overview
Supplement procedures reinforce or augment an upper-body vein that remains anatomically in place by adding biological or synthetic material onto or into it, without removing the vein itself. This is typically done to strengthen a weakened vein wall, widen a narrowed segment with a patch, or add support to a vein used for vascular access so it can better withstand repeated needle sticks or higher blood flow, such as when a dialysis fistula vein is patched to improve its diameter.
Unlike replacement, the patient's own vein tissue is preserved and left functioning; the added material works alongside it rather than substituting for it. This makes Supplement a less invasive option than Replacement when the vein wall is intact enough to be reinforced rather than excised.
Anatomy & Axis Detail
Cephalic Vein, Left
The left cephalic vein ascends the lateral forearm and upper arm and, like its right-sided counterpart, is a frequent target for hemodialysis access. A supplement procedure on this vessel typically addresses a segment weakened by aneurysmal degeneration, stenosis-related wall thinning, or prior instrumentation, using patch material to reinforce rather than replace the vein wall. Because the cephalic vein's superficial course makes it both a favored access site and vulnerable to repeated needle trauma, documentation of the specific reinforced segment and the material used is important for accurate coding. The left-sided designation should be confirmed against the operative note, as laterality is a required distinction from the right cephalic vein and cannot be inferred from technique alone.
Approach: Percutaneous
Percutaneous describes entry by needle or instrument puncture through the skin or mucous membrane to reach the site of the procedure, without cutting the tissue open or using a visualizing scope. It differs from Open in that the site itself is never exposed, and from Percutaneous Endoscopic in that no endoscope is used to see internal structures. Common examples include needle biopsies and injections.
Device: Autologous Tissue Substitute
Autologous Tissue Substitute identifies a device value where material harvested from the patient's own body, such as an autograft, is used to replace or reconstruct a body part. Its defining feature is tissue origin from the patient, setting it apart from Nonautologous Tissue Substitute, sourced from a donor or animal, and Synthetic Substitute, made of manufactured material.
Coding & Documentation
Documentation supporting Supplement includes terms like "venoplasty with patch graft," "reinforcement of vein wall," or "angioplasty patch" applied to a named upper vein, with the key detail being that the native vein was not removed. The material used - autologous patch, bovine pericardium, synthetic patch - should be identified because it maps to a specific device or material value in the code.
Coders most often err by defaulting to Replacement whenever graft material is mentioned, without confirming whether the original vein segment was excised (Replacement) or simply reinforced in place (Supplement). Another frequent issue is missing Supplement entirely when a patch angioplasty is performed on a vein during a larger vascular access procedure, since it can be overshadowed in the note by the primary access-creation procedure.